Task: Answer the MCQ question.
Query: Which drug exhibits a -16.481% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) COc1cccc(NC(=O)CSc2nc3ccccc3n2C)c1
(b) COc1cc(OC)cc(-c2nc3ccccc3c(=O)n2NC(=O)c2cccnc2Cl)c1
Answer: a. COc1cccc(NC(=O)CSc2nc3ccccc3n2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(NC(=O)CSc2nc3ccccc3n2C)c1
COc1cccc(NC(=O)CSc2nc3ccccc3n2C)c1
N-(3-methoxyphenyl)-2-(1-methylbenzimidazol-2-yl)sulfanylacetamide